The effect of mailed outreach on FIT completion among patients aged 45-50 in a safety net healthcare system.

Colorectal neoplasms Diagnosis Early detection of cancer Humans Methods Middle aged Safety-net providers

Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
01 Jun 2024
Historique:
received: 13 03 2024
accepted: 13 05 2024
medline: 1 6 2024
pubmed: 1 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

Colorectal cancer screening is recommended starting at age 45, but there has been little research on strategies to promote screening in patients younger than 50. An outreach program quasi-randomly assigned patients aged 45-50 without recent fecal immunochemical test (FIT), colonoscopy or contraindications to screening to two intervention arms: electronic outreach with email and text (electronic outreach only) versus electronic outreach plus mailed outreach with FIT, an instructional letter and a prepaid return envelope (mailed + electronic outreach). In response to known disparities in screening uptake, all Black patients were assigned to receive mailed + electronic outreach. Among patients quasi-randomly assigned to an intervention (non-Black patients), the 180-day FIT completion rate was 18.8% in the electronic outreach only group (n = 1,318) and 25.0% in the mailed + electronic outreach group (n = 1,364) (difference 6.2% [95% CI 3.0, 9.4]). FIT completion was 16.6% among Black patients (n = 469), 8.4% (95% CI 4.1, 12.6) lower than among non-Black patients also assigned to mailed + electronic outreach. Among patients aged 45-50, mailed + electronic outreach had a greater effect on FIT completion than electronic outreach alone. Crossover between intervention groups likely lead to an underestimation of the effect of mailed outreach.

Identifiants

pubmed: 38822978
doi: 10.1007/s10552-024-01889-x
pii: 10.1007/s10552-024-01889-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : HRSA
ID : T32 HP 19025

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Sinicrope FA (2022) Increasing incidence of early-onset colorectal cancer. N Engl J Med 386(16):1547–1558. https://doi.org/10.1056/NEJMra2200869
doi: 10.1056/NEJMra2200869 pubmed: 35443109
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK (2021) ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 116(3):458–479. https://doi.org/10.14309/ajg.0000000000001122
doi: 10.14309/ajg.0000000000001122 pubmed: 33657038
Patel SG et al (2022) Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. multi-society task force on colorectal cancer. Gastroenterology 162(1):285–299. https://doi.org/10.1053/j.gastro.2021.10.007
doi: 10.1053/j.gastro.2021.10.007 pubmed: 34794816
US Preventive Services Task Force et al (2021) Screening for colorectal cancer preventive services task force recommendation statement. JAMA 325(19):1965–1977. https://doi.org/10.1001/jama.2021.6238
doi: 10.1001/jama.2021.6238
Shaukat A, Levin TR (2022) Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol 19(8):521–531. https://doi.org/10.1038/s41575-022-00612-y
doi: 10.1038/s41575-022-00612-y pubmed: 35505243 pmcid: 9063618
Singal AG et al (2016) Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer 122(3):456–463. https://doi.org/10.1002/cncr.29770
doi: 10.1002/cncr.29770 pubmed: 26535565
Levin TR et al (2018) Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology 155(5):1383-1391.e5. https://doi.org/10.1053/j.gastro.2018.07.017
doi: 10.1053/j.gastro.2018.07.017 pubmed: 30031768
Somsouk M et al (2020) Effectiveness and cost of organized outreach for colorectal cancer screening: a randomized, controlled trial. J Natl Cancer Inst 112(3):305–313. https://doi.org/10.1093/jnci/djz110
doi: 10.1093/jnci/djz110 pubmed: 31187126
Gupta S et al (2013) Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med 173(18):1725–1732
pubmed: 23921906 pmcid: 5228201
O’Leary MC et al (2023) Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45–49-year-old community health center population. Cancer Causes Control. https://doi.org/10.1007/s10552-023-01717-8
doi: 10.1007/s10552-023-01717-8 pubmed: 37731072 pmcid: 10689519
Coronado GD, Dickerson JF, Burnett-Hartman AN, Carethers JM, Lee JK, McBurnie MA (2023) Reduced implementation and completion of average-risk annual fecal immunochemical test colorectal cancer screening in black patients aged 45–49 years. Clin Gastroenterol Hepatol 21(7):1937–1939. https://doi.org/10.1016/j.cgh.2022.05.009
doi: 10.1016/j.cgh.2022.05.009 pubmed: 35644342
United States Postal Service, (2018) Millenials and the Mail, https://www.oversight.gov/sites/default/files/oig-reports/RARC-WP-18-011.pdf
Health Equity Resolution. 2020. https://www.sfdph.org/dph/hc/HCAgen/HCAgen2020/July%2021/20_10%20Anti_Black_Racism_Is_Public_Health_Crisis_072120F.pdf
Newcombe RG (1998) Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17(8):873–890
doi: 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I pubmed: 9595617
Dougherty MK et al (2018) Evaluation of interventions intended to increase colorectal cancer screening rates in the united states: a systematic review and meta-analysis. JAMA Intern Med 178(12):1645–1658. https://doi.org/10.1001/jamainternmed.2018.4637
doi: 10.1001/jamainternmed.2018.4637 pubmed: 30326005 pmcid: 6583619
Gupta SK (2011) Intention-to-treat concept: a review. Perspect Clin Res 2(3):109–112. https://doi.org/10.4103/2229-3485.83221
doi: 10.4103/2229-3485.83221 pubmed: 21897887 pmcid: 3159210
Baker DW et al (2014) Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med 174(8):1235–1241. https://doi.org/10.1001/jamainternmed.2014.2352
doi: 10.1001/jamainternmed.2014.2352 pubmed: 24934845
Goldman SN et al (2015) Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in community health centers: a randomized controlled trial. J Gen Intern Med 30(8):1178–1184. https://doi.org/10.1007/s11606-015-3234-5
doi: 10.1007/s11606-015-3234-5 pubmed: 25814264 pmcid: 4510220
Doubeni CA, Rustgi A (2015) Racial disparities in colorectal cancer survival: is elimination of variation in care the cure? J Natl Cancer Inst. https://doi.org/10.1093/jnci/djv229
doi: 10.1093/jnci/djv229 pubmed: 26220735
Rutter CM, Knudsen AB, Lin JS, Bouskill KE (2021) Black and white differences in colorectal cancer screening and screening outcomes: a narrative review. Cancer Epidemiol Biomarkers Prev 30(1):3–12. https://doi.org/10.1158/1055-9965.EPI-19-1537
doi: 10.1158/1055-9965.EPI-19-1537 pubmed: 33144285
Liss DT, Baker DW (2014) Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med 46(3):228–236. https://doi.org/10.1016/j.amepre.2013.10.023
doi: 10.1016/j.amepre.2013.10.023 pubmed: 24512861
Burgess DJ et al (2011) Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med 26(3):251–258. https://doi.org/10.1007/s11606-010-1575-7
doi: 10.1007/s11606-010-1575-7 pubmed: 21088920
Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH (2004) Socioeconomic and racial patterns of colorectal cancer screening among medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 18(8):2170–2175. https://doi.org/10.1158/1055-9965.EPI-09-0104
doi: 10.1158/1055-9965.EPI-09-0104
Braveman PA, Arkin E, Proctor D, Kauh T, Holm N (2022) Systemic and structural racism: definitions, examples, health damages, and approaches to dismantling. Health Aff 41(2):171–178. https://doi.org/10.1377/hlthaff.2021.01394
doi: 10.1377/hlthaff.2021.01394
Grubbs SS et al (2013) Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol 31(16):1928–1930. https://doi.org/10.1200/JCO.2012.47.8412
doi: 10.1200/JCO.2012.47.8412 pubmed: 23589553 pmcid: 3661932
Brown JJ et al (2021) Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening. BMC Public Health 21(1):1280. https://doi.org/10.1186/s12889-021-11330-6
doi: 10.1186/s12889-021-11330-6 pubmed: 34193094 pmcid: 8247120

Auteurs

Sean P McClellan (SP)

Department of Family and Community Medicine, University of California, San Francisco, CA, USA. smccle2@uic.edu.
Department of Family and Community Medicine, University of Illinois, Chicago, IL, USA. smccle2@uic.edu.

Tanya Khan (T)

Division of Gastroenterology, University of California, San Francisco, CA, USA.

Henry Rafferty (H)

San Francisco Health Network, San Francisco, CA, USA.

Jonathan Wong (J)

San Francisco Health Network, San Francisco, CA, USA.

Sylvia La (S)

San Francisco Health Network, San Francisco, CA, USA.

Shreya Patel (S)

Division of Gastroenterology, University of California, San Francisco, CA, USA.
Division of Gastroenterology, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.

Ma Somsouk (M)

Division of Gastroenterology, University of California, San Francisco, CA, USA.
Division of Gastroenterology, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.

Classifications MeSH